A Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis
Sponsor: Novartis Pharmaceuticals
Memphis, TN · Colleyville, TX · San Antonio, TX
8 recruiting Phase 2 psoriasis studies in the US. What trial phases mean
Sponsor: Novartis Pharmaceuticals
Memphis, TN · Colleyville, TX · San Antonio, TX
Sponsor: LEO Pharma
Fountain Valley, CA · Douglasville, GA · West Bloomfield, MI · +4 more sites
Sponsor: Janssen Research & Development, LLC
Searcy, AR · Huntington Beach, CA · San Diego, CA · +15 more sites
Sponsor: Oruka Therapeutics, Inc.
Phoenix, AZ · Fountain Valley, CA · Los Angeles, CA · +19 more sites
Sponsor: Merck Sharp & Dohme LLC
Sun City, AZ · Tucson, AZ · Riverside, CA · +15 more sites
Sponsor: NYU Langone Health
New York, NY
Sponsor: InventisBio Co., Ltd
Birmingham, AL · Phoenix, AZ · Chula Vista, CA · +17 more sites
Sponsor: AbbVie
Huntington Beach, CA · Avon Park, FL · Clearwater, FL · +13 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.